Abstract
Ten patients had serial evaluations of plasma prostaglandin E2, prostaglandin 2α, and 6-keto-PG1α during administration of cis-platinum chemotherapy. No significant changes were noted in PGF2α and 6-keto-PGF1α whereas PGE2 showed a decrease. This would indicate that the nausea and vomiting of platinum therapy is not a result of tumor release of prostaglandins. All patients had known residual cancer and all had elevated levels of PGE2 and 6-keto-PGF1α.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 89-91 |
| Number of pages | 3 |
| Journal | Gynecologic Oncology |
| Volume | 12 |
| Issue number | 1 |
| DOIs | |
| State | Published - Aug 1981 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
All Science Journal Classification (ASJC) codes
- Oncology
- Obstetrics and Gynecology
Fingerprint
Dive into the research topics of 'The role of prostaglandins in the excessive nausea and vomiting after intravascular cis-platinum therapy'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver